Answers are grounded in this paper and cite their sources.
Demonstrates XGBoost accurately classifies prostate cancer stages in racial groups, suggesting improvements in detection.
Background/Aim: Prostate cancer has a high mortality rate and shows diagnostic disparities between racial groups, particularly between White and Black populations. This study aimed to develop a prostate cancer stage classification model using the XGBoost algorithm on miRNA expression data with a focus on race-based analysis. Materials and Data balancing techniques such as RandomOversampler, SMOTE, SMOTEENN, and BorderlineSMOTE were also implemented to address class imbalance. Results: The results showed that the XGBoost model achieved an accuracy of up to 89% on data from White patients. Additionally, the F1-score shows the results of 92%, these results suggest this model is particularly strong in identifying minority class in this unbalance data. However, when tested on data from Black patients, the accuracy decreased to 72-74%, indicating limitations in cross-race performance. Additionally, Local Interpretable Model-agnostic Explanations (LIME) was implemented to identify the gene features that contributed most significantly to the model's predictions. Conclusion: The study demonstrates that XGBoost, combined with race-specific feature selection and hyperparameter tuning, can accurately detect prostate cancer with high performance. These findings highlight the potential of XGBoost for improving prostate cancer detection while also emphasizing the importance of considering race-specific differences in machine learning models.
No takes yet. Share an insight, caveat, or question.
Syechlo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: